Literature DB >> 16084658

Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat.

K G Shields1, R J Storer, S Akerman, P J Goadsby.   

Abstract

Clinical observations and genetic studies have suggested a role for high-threshold voltage-dependent calcium channels (VDCCs) in the pathogenesis of migraine. This study investigated the role of P/Q-, L- and N-type VDCCs in post-synaptic action potential generation in trigeminovascular nociceptive afferents in the trigeminocervical complex (TCC) of the cat in vivo. Trigeminovascular nociceptive afferents were identified in the TCC by electrical stimulation of the superior sagittal sinus. Forty-six cell bodies were identified by their response to microiontophoresis of l-glutamate and their bipolar action potential shape. Blockade of VDCCs was accomplished by microiontophoresis of omega-agatoxin IVa/TK (P/Q-), omega-conotoxin GVIa (N-) and calciseptine (L-type). Non-selective antagonism was studied using cadmium ions. Non-selective blockade of high threshold VDCC with cadmium resulted in a reduction in l-glutamate-evoked neuronal activity (P=0.01). Blockade of P/Q: TK- (P<0.001), IVA- (P=0.007), L- (P<0.001) and N-type (P<0.001) VDCCs resulted in significant reductions in post-synaptic action potential generation in response to l-glutamate. High threshold VDCCs, including P/Q-, L- and N-type VDCCs, can therefore modulate nociceptive transmission in the trigeminocervical complex in vivo. We discuss the evidence to suggest a role for VDCCs in the pathophysiology of primary headache disorders, and how abnormalities of function may contribute to their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084658     DOI: 10.1016/j.neuroscience.2004.08.054

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  4 in total

1.  Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain.

Authors:  Asha Nair; Manuela Simonetti; Nicol Birsa; Michel D Ferrari; Arn M J M van den Maagdenberg; Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Pain       Date:  2010-08-24       Impact factor: 3.395

Review 2.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

3.  Efficacy of (S)-Lacosamide in preclinical models of cephalic pain.

Authors:  Aubin Moutal; Nathan Eyde; Edwin Telemi; Ki Duk Park; Jennifer Y Xie; David W Dodick; Frank Porreca; Rajesh Khanna
Journal:  Pain Rep       Date:  2016-06

4.  Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling.

Authors:  Yan Xiao; Judith A Richter; Joyce H Hurley
Journal:  Mol Pain       Date:  2008-04-16       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.